In patients with diabetes and prolonged hyperglycemia, abnormal levels of serum biomarkers of inflammation and oxidative stress including NF-κB and IL-6 are evident together with aberrant free fatty acid (FFA) metabolism. The gene discussed is NFKB1; the disease is diabetes mellitus.